Bakshi Akash 4

4 · NeuroBo Pharmaceuticals, Inc. · Filed Jan 5, 2021

Insider Transaction Report

Form 4
Period: 2020-12-31
Bakshi Akash
DirectorSVP and COO
Transactions
  • Award

    Common Stock

    2020-12-31+855,059884,072 total(indirect: See Footnote)
  • Award

    Common Stock

    2020-12-31+29,01329,013 total
Footnotes (2)
  • [F1]Received in exchange for shares of ANA Therapeutics, Inc. ("ANA") common stock in connection with the acquisition of ANA by the Company.
  • [F2]The reportable securities are owned directly by YourChoice Holdings, LLC ("YourChoice"). Mr. Bakshi is the CEO and a director of YourChoice. Mr. Bakshi disclaims beneficial ownership of the securities reported herein for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any.

Documents

1 file
  • 4
    a4.xmlPrimary

    4